Interclean Shanghai

WellSky to Acquire TapCloud to Bolster Patient Engagement Technology That Improves the Patient Experience and Lowers Costs

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

WellSky, a global health and community care technology company, announced that it intends to acquire TapCloud, a virtual patient engagement technology company that helps patients, caregivers, and clinicians communicate crucial information in real-time to achieve better health outcomes.

Frequent communication between patients, clinicians, and payers is critical to providing quality care and delivering on value-based care. TapCloud’s interoperable, AI-driven platform provides real-time, patient-generated insights, enabling providers to deploy care interventions aimed at reducing preventable hospital readmissions and emergency care.

“WellSky is connecting every part of health and community care, and TapCloud represents a significant addition to our suite of solutions. By adding these robust capabilities, WellSky will further extend our position as the leading technology and analytics partner across the continuum,” said Bill Miller, CEO of WellSky. “Together, WellSky and TapCloud will enable providers to make evidence-based decisions, powered by actionable analytics. With this new level of patient visibility, our clients can achieve better outcomes, lower costs, and ultimately, succeed in value-based care.”

Using TapCloud’s EHR-agnostic patented technology, patients can share their symptoms and other pertinent data with providers using virtual visit technology, secure messaging, and remote symptom screening protocols. The combination of TapCloud’s user-friendly technology and WellSky’s deep experience in predictive analytics opens new possibilities for providers and payers as they seek to increase collaboration and better coordinate care.

“TapCloud has worked tirelessly to close the communication gap between patients and providers through the use of data and technology. With WellSky, we gain access to a larger network and increased investment, which will broaden our reach and allow even more patients and families to be active participants in their care journeys,” said Phil Traylor, CEO of TapCloud. “Together, we are well-positioned to expand the ways we can help our clients be successful, no matter which EHR platform they use. I’m excited to see how we will innovate together.”

WellSky will integrate TapCloud’s platform into its healthcare technology solutions that more than 5 million caregivers use each day. Over time, WellSky will?expand its extensive clinical dataset to include TapCloud’s patient-generated data, enabling the?development of?new models that allow providers, payers, and other risk-bearing entities to?better?predict patient risk factors and deploy interventions.

The transaction is subject to customary closing conditions and is expected to close shortly.

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »